ConductScience.org, home

Paper34722192

Guidelines for Prevention and Treatment of Chronic Hepatitis B.

Wang G and 1 other. J Clin Transl Hepatol, 2021. Cited by 74 papers, by iCite.

Cite this record

ConductScience Library. Guidelines for Prevention and Treatment of Chronic Hepatitis B. Papers, record 34722192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34722192

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Guidelines for Prevention and Treatment of Chronic Hepatitis B.
PubMed
Journal
J Clin Transl Hepatol
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
74
iCite
Relative citation ratio, by iCite
4.86
iCite
Revised in PubMed
2026-10-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang GGuiqiang
2Duan ZZhongpinghttps://orcid.org/0000-0002-9397-6330

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT05937178Real-world Study Optimizing Nucleotide-analoguesBackgroundClinicalTrials.gov
NCT06041022A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis BBackgroundClinicalTrials.gov

Download CSV of trials

References215

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129056008[Clinical effect and safety of pegylated interferon-α-2b injection (Y shape, 40 kD) in treatment of HBeAg-positive chronic hepatitis B patients].Zhonghua Gan Zang Bing Za Zhi2017https://conductscience.org/library/papers/29056008PubMed
227634134Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.Liver Int2016https://conductscience.org/library/papers/27634134PubMed
329156044Characteristics, Prevention, and Management of Hepatitis B Virus (HBV) Reactivation in HBV-Infected Patients Who Require Immunosuppressive Therapy.J Infect Dis2017https://conductscience.org/library/papers/29156044PubMed
428668465
Screening, monitoring, prevention, prophylaxis and therapy for hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation: a systematic review.
Clin Microbiol Infect2017https://conductscience.org/library/papers/28668465PubMed
526727044Hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy in patients with diffuse large B cell lymphoma.Leuk Lymphoma2016https://conductscience.org/library/papers/26727044PubMed
628418296Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China.Emerg Infect Dis2017https://conductscience.org/library/papers/28418296PubMed
726563120Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Hepatol Int2016https://conductscience.org/library/papers/26563120PubMed
822052888Prevalence of and risk factors for hepatitis B viremia after spontaneous hepatitis B surface antigen seroclearance in hepatitis B carriers.Clin Infect Dis2012https://conductscience.org/library/papers/22052888PubMed
929456079Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B.J Formos Med Assoc2018https://conductscience.org/library/papers/29456079PubMed
1028681347New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.Hepatol Int2018https://conductscience.org/library/papers/28681347PubMed
1112616450Natural history and prognosis of hepatitis B.Semin Liver Dis2003https://conductscience.org/library/papers/12616450PubMed
1229353469Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend.Clin Mol Hepatol2018https://conductscience.org/library/papers/29353469PubMed
1327992681Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA.Liver Int2017https://conductscience.org/library/papers/27992681PubMed
1416673292Hepatitis B virus-related cirrhosis: natural history and treatment.Semin Liver Dis2006https://conductscience.org/library/papers/16673292PubMed
1530876946Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial.J Hepatol2019https://conductscience.org/library/papers/30876946PubMed
167806171Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis.Hepatology1995https://conductscience.org/library/papers/7806171PubMed
1716557381Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial.J Cancer Res Clin Oncol2006https://conductscience.org/library/papers/16557381PubMed
1821907650Improving transient elastography performance for detecting hepatitis B cirrhosis.Dig Liver Dis2012https://conductscience.org/library/papers/21907650PubMed
1925546679Antibody to hepatitis B core antigen levels in the natural history of chronic hepatitis B: a prospective observational study.Medicine (Baltimore)2014https://conductscience.org/library/papers/25546679PubMed
2017628874Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase.Hepatology2007https://conductscience.org/library/papers/17628874PubMed

See all 215 referencesDownload CSV of references

Cited by50

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMIDTitleJournalYearIn PapersSource
42797837Weekly HBsAg Decline Dynamics During Combination Therapy with Interferon and Nucleos(t)ide Analogs: A Retrospective Real-World Study.Viruses2026https://conductscience.org/library/papers/42797837PubMed
42373438[Clinical study on the efficacy of Wuling capsules combined with nucleos(t)ide analogues in the treatment of low-level viremia patients with chronic hepatitis B].Zhonghua Gan Zang Bing Za Zhi2026https://conductscience.org/library/papers/42373438PubMed
42168925Changes in myeloid-derived suppressor cells and cytokine expression during mother-to-child transmission prevention in HBeAg-positive pregnant women with chronic hepatitis B.BMC Infect Dis2026https://conductscience.org/library/papers/42168925PubMed
42096447Identification and functional analysis of key miRNAs and target genes associated with failure of HBV mother-to-child transmission prevention.PLoS One2026https://conductscience.org/library/papers/42096447PubMed
41495701Real-world efficacy of comprehensive measures against mother-to-child transmission of HBV in south-eastern Jiangsu, China.BMC Infect Dis2026https://conductscience.org/library/papers/41495701PubMed
41322205Optimized strategy of switching to tenofovir alafenamide fumarate treatment for nucleos(t)ide analogue experienced patients with chronic hepatitis B.Front Med (Lausanne)2025https://conductscience.org/library/papers/41322205PubMed
40995139Chemotherapy drugs do not affect the production of hepatitis B surface antibodies: A case report.Oncol Lett2025https://conductscience.org/library/papers/40995139PubMed
40887644
Impact of stopping Tenofovir disoproxil fumarate at various times on elevated postpartum ALT levels and breastfeeding in pregnant women with chronic hepatitis B: a prospective observational cohort study.
BMC Pregnancy Childbirth2025https://conductscience.org/library/papers/40887644PubMed
40636089Serum IP-10 increase correlated with PEG-IFNα response in nucleot(s)ide analogs-treated patients with chronic hepatitis B.ILIVER2024https://conductscience.org/library/papers/40636089PubMed
40385030Tenofovir disoproxil fumarate: safe and effective option for managing high-viral-load chronic hepatitis B.Am J Transl Res2025https://conductscience.org/library/papers/40385030PubMed
40344467Chemoprevention of Gastrointestinal Cancers: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials and Cohort Studies.Clin Transl Sci2025https://conductscience.org/library/papers/40344467PubMed
40044428[Recent advances in epidemiology, prevention and treatment of hepatitis B in China].Zhonghua Gan Zang Bing Za Zhi2025https://conductscience.org/library/papers/40044428PubMed
40003989Evaluation of the Potency of Repurposed Antiretrovirals in HBV Therapy: A Narrative Investigation of the Traditional Medicine Alternatives.Int J Mol Sci2025https://conductscience.org/library/papers/40003989PubMed
39775320The prognosis and immune repertoire characteristics of HBsAg and anti-HBs double positive chronic hepatitis B patients.Clin Exp Med2025https://conductscience.org/library/papers/39775320PubMed
39744198Hepatitis B virus-induced cirrhosis: Mechanisms, global variations, and treatment advances.World J Hepatol2024https://conductscience.org/library/papers/39744198PubMed
39720865HBV-Induced Carcinogenesis: Mechanisms, Correlation With Viral Suppression, and Implications for Treatment.Liver Int2025https://conductscience.org/library/papers/39720865PubMed
39391516Trajectory and predictors of adherence to Nucleos(t)ide analogues medication among patients with chronic hepatitis B.Heliyon2024https://conductscience.org/library/papers/39391516PubMed
39328404Peripheral NK cell phenotypic alteration and dysfunctional state post hepatitis B subviral particles stimulation in CHB patients: evading immune surveillance.Front Immunol2024https://conductscience.org/library/papers/39328404PubMed
38798823A new approach to prevent, diagnose, and treat hepatitis B in Africa.BMC Glob Public Health2023https://conductscience.org/library/papers/38798823PubMed
38617970Development of novel prognostic models based on dynamic changes in risk factors for hepatitis B associated acute-on-chronic liver failure:a 10-year retrospective study.Heliyon2024https://conductscience.org/library/papers/38617970PubMed

See all 50 cited byDownload CSV of cited by

Genes20

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE1636PubTator's text mininghttps://conductscience.org/library/genes/1636NCBI Gene
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
ALPP250PubTator's text mininghttps://conductscience.org/library/genes/250NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CHI3L11116PubTator's text mininghttps://conductscience.org/library/genes/1116NCBI Gene
CHP111261PubTator's text mininghttps://conductscience.org/library/genes/11261NCBI Gene
COL3A11281PubTator's text mininghttps://conductscience.org/library/genes/1281NCBI Gene
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
CSF31440PubTator's text mininghttps://conductscience.org/library/genes/1440NCBI Gene
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene
GGT12678PubTator's text mininghttps://conductscience.org/library/genes/2678NCBI Gene
GOLM151280PubTator's text mininghttps://conductscience.org/library/genes/51280NCBI Gene
GPT2875PubTator's text mininghttps://conductscience.org/library/genes/2875NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
SLC10A16554PubTator's text mininghttps://conductscience.org/library/genes/6554NCBI Gene
SLC17A526503PubTator's text mininghttps://conductscience.org/library/genes/26503NCBI Gene
STAT46775PubTator's text mininghttps://conductscience.org/library/genes/6775NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34722192

GET https://conductscience.org/api/papers/v1/34722192/references?page=2